Bristol-Myers Squibb Co 

BMY:NYSE

LastChange / % ChangeDividend YieldVolumeAvg Volume (10 day)
43.30 0.53   1.24%3.23%11,130,08613.2M

Market data is delayed by at least 20 minutes.

 
 
 
 
 
 
 
 
 
5/18/2013 6:06 AM ET
Market ComparisonP/E (TTM)P/E (Forward
12 Months)
PEG1 Year EPS
Growth Rate
5 Year EPS
Growth Rate
BMY
Bristol-Myers Squibb Co
49.435.15.2-46.16%12.31%
Biotechnology & Drugs
Industry
51.816.03.512.15%8.06%
Healthcare
Sector
24.917.84.1-48.30%6.80%
S&P; 50018.118.93.6-3.64%6.28%

Earnings Summary

On 4/25/2013, BMY reported 1 quarter 2013 earnings of $0.41 per share. This result was in-line with the consensus of the 14 analysts following the company and missed last year's 1 quarter results by 35.94%.


BMY's PE ratio is among the highest of any stock in the Biotechnology & Drugs industry and signals that investors have high hopes for this company's future business prospects. However, during the past year, earnings growth has lagged its historical five year growth rate.